Re: Crispr-cas9 Patent Dispute -- Off-topic? Or do we have a similar situation?
|
1
|
Resverlogix Corp.
|
Oct 31, 2016 11:47AM
|
Re: Critique rvx-208 Science
|
5
|
Resverlogix Corp.
|
Nov 25, 2015 12:11PM
|
Re: CTAD Asia Alzheimer's Conference Sept 1 & 2
|
10
|
Resverlogix Corp.
|
Sep 01, 2018 09:31AM
|
Re: CTAD Poster - as posted 12/07/2019
|
3
|
Resverlogix Corp.
|
Dec 08, 2019 02:38PM
|
Re: Cummings
|
5
|
Resverlogix Corp.
|
Dec 04, 2019 08:32AM
|
Re: Curiosity questions
|
2
|
Resverlogix Corp.
|
Mar 01, 2020 09:01PM
|
Re: Current Status of Draft Checklist
|
3
|
Resverlogix Corp.
|
Jul 26, 2016 11:34AM
|
Re: Current Status of Draft Checklist
|
1
|
Resverlogix Corp.
|
Jul 26, 2016 07:44PM
|
Re: Current Status of Draft Checklist... thumbs up...!
|
2
|
Resverlogix Corp.
|
Jul 28, 2016 12:32PM
|
Re: Current Status of Draft Checklist... thumbs up...!
|
2
|
Resverlogix Corp.
|
Jul 27, 2016 01:07PM
|
Re: Current Status of Draft Checklist... thumbs up...!
|
1
|
Resverlogix Corp.
|
Jul 28, 2016 08:58AM
|
Re: CVOTs on the Horizon
|
2
|
Resverlogix Corp.
|
Oct 01, 2018 04:22PM
|
Re: CVOTs on the Horizon
|
6
|
Resverlogix Corp.
|
Oct 01, 2018 05:48PM
|
Re: CVOTs on the Horizon
|
5
|
Resverlogix Corp.
|
Oct 04, 2018 11:42AM
|
Re: CVOTs on the Horizon
|
2
|
Resverlogix Corp.
|
Oct 02, 2018 10:02AM
|
Re: CVOTs on the Horizon
|
3
|
Resverlogix Corp.
|
Oct 02, 2018 10:48AM
|
Re: Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies
|
8
|
Resverlogix Corp.
|
Apr 27, 2020 02:27PM
|
Re: Danish cancer breakthrough
|
2
|
Resverlogix Corp.
|
Oct 15, 2015 11:01AM
|
Re: DAPA HF
|
7
|
Resverlogix Corp.
|
Sep 05, 2019 07:51PM
|
Re: Data Lock - what does it mean for the BoM study and for investors? ...
|
2
|
Resverlogix Corp.
|
Jun 07, 2019 04:52PM
|